Not logged in
Share
Save
Share
Save
Share
SaveAlectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study
Zhang, Haoran; Wu, Zhaozhen; Lu, Tao; Zhang, Hui; Li, Ji; Zhang, Dongming; Yu, Siyuan; Guo, Xiaobei; Feng, Xiaoyi; Liu, Jia; Shi, Yuequan; Gao, Xiaoxing; Liu, Xiaoyan; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Hu, Ying; Xu, Yan; Wang, Mengzhao
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save